Jubilant Pharmova Ltd reports consolidated Q1FY24 profit of Rs. 6.4 crores

Jubilant Pharmova Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 1595.5 crores during the period ended June 30, 2023 as compared to Rs. 1682.4 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 6.4 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -97.9 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 0.40 for the period ended June 30, 2023 as compared to Rs. -6.15 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹1595.5 crs	₹1682.4 crs	-5.17%
Net Profit	₹6.4 crs	₹-97.9 crs	106.54%
EPS	₹0.40	₹-6.15	106.50%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs.1595.5 crores during the period ended June 30, 2023 as compared to Rs.1463 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.6.4 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.47.1 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.0.40 for the period ended June 30, 2023 as compared to Rs.2.96 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹1595.5 crs	₹1463 crs	9.06%
Net Profit	₹6.4 crs	₹47.1 crs	-86.41%
EPS	₹0.40	₹2.96	-86.49%

Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 386.30 as compared to the previous close of Rs. 398.15. The total number of shares traded during the day was 112375 in over 4642 trades.

The stock hit an intraday high of Rs. 408.90 and intraday low of 375.50. The net turnover during the day was Rs. 43811251.00.

Source : Equity Bulls

Keywords

JubilantPharmova Q1FY24 ResultUpdate